Association Between Continuous Glucose Monitoring-Derived Glycemia Risk Index and Albuminuria in Type 2 Diabetes
Diabetes Technology & Therapeutics · 2023
DOI: 10.1089/dia.2023.0165 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes Technology & Therapeutics, 2023. Verfasst von Jee Hee Yoo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Medicine, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Albuminuria, Blood Glucose, Diabetic Nephropathies. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
The glycemia risk index (GRI) is a new composite metric derived from continuous glucose monitoring (CGM) data to assess the quality of glycemia. This study investigates the association between the GRI and albuminuria.
Methods
Professional CGM and urinary albumin-to-creatinine ratio (UACR) data from 866 individuals with type 2 diabetes were retrospectively reviewed. Albuminuria and macroalbuminuria were defined as one or more UACR measurements ≥30 and ≥300 mg/g, respectively.
Results
The overall prevalence of albuminuria and macroalbuminuria was 36.6% and 13.9%, respectively. Participants with a higher UACR had a significantly higher hyperglycemia component and GRI score than those with a lower UACR (all P < 0.001), although the hypoglycemia component did not differ among the groups. Multiple logistic regression analyses that adjusted for various factors affecting albuminuria revealed that the odds ratio (OR) of albuminuria was 1.13 (95% confidence interval [CI]: 1.02–1.27, P = 0.039) per increase in the GRI zone. The results were similar for the risk of macroalbuminuria (OR: 1.42 [95% CI: 1.20–1.69], P < 0.001), and that association remained after adjusting for glycated hemoglobin (OR: 1.31 [95% CI: 1.10–1.58], P = 0.004).
Conclusions
GRI is strongly associated with albuminuria, especially macroalbuminuria, in type 2 diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology and Metabolism, Department of Medicine, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea.
- Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
ORCID-Profile: Jae Hyeon Kim
Zitieren
APA
Yoo, J. H., Kim, J. Y., & Kim, J. H. (2023). Association Between Continuous Glucose Monitoring-Derived Glycemia Risk Index and Albuminuria in Type 2 Diabetes. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2023.0165
Vancouver
Yoo JH, Kim JY, Kim JH. Association Between Continuous Glucose Monitoring-Derived Glycemia Risk Index and Albuminuria in Type 2 Diabetes. Diabetes Technology & Therapeutics. 2023. doi:10.1089/dia.2023.0165
BibTeX
@article{Yoo2023,
author = {Yoo, Jee Hee and Kim, Ji Yoon and Kim, Jae Hyeon},
title = {Association Between Continuous Glucose Monitoring-Derived Glycemia Risk Index and Albuminuria in Type 2 Diabetes},
journal = {Diabetes Technology & Therapeutics},
year = {2023},
doi = {10.1089/dia.2023.0165}
}
EUVIMED